/Investor DB

TPG — 2018 Investments

4 investments dated 2018 · listed companies and verified rows first · show all

Allogene Therapeuticsallogene.comin𝕏NASDAQ: ALLOApr 2018

Allogene Therapeutics develops allogeneic CAR T cell therapies (AlloCAR T) for blood cancers, solid tumors, and autoimmune diseases, using off-the-shelf manufactured cell products rather than patient-derived autologous approaches.

BiotechHealthtechMedical DevicesSouth San Francisco, US

Arie Belldegrun, M.D.(Executive Chairman and Co-Founder)inDavid Chang, M.D., Ph.D.(Co-Founder, Allogene; former President and Chief Executive Officer)Christine Cassiano(Executive Vice President, Chief Corporate Affairs and Brand Strategy Officer; one of the founders of Allogene)inZachary Roberts, M.D., Ph.D.(President and Chief Executive Officer)ROBERT ABRAHAM(Director)JOSHUA A. KAZAM(Co-Founder and Director of Allogene)

Co-investorsAvoro Capital AdvisorsForesite CapitalVida VenturesGilead SciencesVVAG Special

C3 AIc3.aiin𝕏NYSE: AIJan 2018 · $100M

C3 AI develops an enterprise AI platform that unifies data, intelligent agents, and domain-specific AI models to help large organizations make faster and better operational decisions.

AI & Machine LearningEnterprise SoftwareSaaSSector AgnosticSan Jose, US

Thomas M. Siebel(Founder, Chairman, and CEO)inThomas Siebel(CEO and Chairman)inPaul Phillips(Executive Officer)inEd Abbo(Executive Officer, Director)inChristopher Werner(Executive Officer, Director, Promoter)Dana Jurika(Executive Officer, Director, Promoter)

Co-investorsBreyer CapitalConstellation Technology VenturesSutter Hill VenturesThe Rise Fund

Sonatypesonatype.comin𝕏Aug 2018 · $80M

Sonatype provides software supply chain management and security solutions for managing open source software and AI dependencies.

CybersecurityDeveloper ToolsEnterprise SoftwareFulton, US

Brian Fox(Chief Technology Officer and co-founder)inWAYNE JACKSON(Executive Officer, Director)inDAVID C. MILLER(Executive Officer)

BoardANN WINBLAD(Director)inSAMEER GANDHI(Director)inMICHAEL O'DELL(Director)

Co-investorsAccelAspenwoodBlue Delta CapitalCanvas VenturesFounders Circle CapitalGolub Growth+3 more

Taniumtanium.comin𝕏May 2018

Tanium offers a unified platform for IT operations and security, combining endpoint management, patching, compliance, vulnerability/exposure management, and threat detection and response driven by AI and real-time endpoint intelligence.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaSEmeryville, US

Orion Hindawi(Executive Officer, Director)inDavid Hindawi(Executive Officer, Director)Eric Brown(Executive Officer)inMichael Carpenter(Executive Officer)

BoardSteven Sinofsky(Director)inNathan Brill(Director)

Co-investorsAndreessen HorowitzBrilliant Phoenix CapitalEQUIAMGeodesic CapitalIVP (Institutional Venture Partners)Junipero+5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.